Thyrotropin releasing hormone (TRH): DOPA potentiation and biogenic amine studies

This publication has 14 references indexed in Scilit:

• A possible mechanism for the anti-depressant activity of thyrotropin releasing hormone
  Life Sciences, 1974
• THYROTROPHIN-RELEASING HORMONE IN THE TREATMENT OF DEPRESSION
  The Lancet, 1974
• A DOUBLE-BLIND CROSSOVER SEQUENTIAL TRIAL OF ORAL THYROTROPHIN-RELEASING HORMONE IN DEPRESSION
  The Lancet, 1974
• Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice
  Pharmacology Biochemistry and Behavior, 1974
• THE USE OF DRUGS IN DEPRESSION: ITS THEORETICAL AND PRACTICAL BASIS
  Psychiatric Annals, 1973
• Thyrotropin Releasing Hormone: Enhancement of Dopa Activity by a Hypothalamic Hormone
  Science, 1972
• DOPA Potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF)
  Life Sciences, 1971
• Indoleamines and Affective Disorders
  Psychosomatic Medicine, 1969
• INTENSIFICATION OF THE CENTRAL SEROTONINERGIC PROCESSES AS A POSSIBLE DETERMINANT OF THE THYMOLEPTIC EFFECT
  Published by Elsevier ,1969
• The Biochemistry of Affective Disorders
  The British Journal of Psychiatry, 1967